mortality/aging
• only 10.8% of homozygous embryos are recovered neonatally but all newborns die within several hours after birth
|
• homozygous embryos are present at Mendelian ratios at E10.5 (22.1%); however, the survival rate drops at E12.5 (20% vs expected 25%), E14.5 (14.9%) and E18.5 (14.6%)
|
homeostasis/metabolism
integument
growth/size/body
• newborns are significantly smaller than wild-type controls
|
• at E18.5, body weight of embryos delivered by Cesarean section is significantly lower than that in wild-type controls
|
cardiovascular system
• at E14.5, embryos exhibit various congenital heart defects
• transgenic overexpression of a C-terminal fragment of Wdfy3 fails to rescue the cardiac defects
|
• at E14.5, all (17 o 17) embryos exhibit disorganized ventricular trabeculation in both left ventricle (LV) and right ventricle (RV)
• disorganized trabeculation is also observed at E12.5, E13.5 and E15.5
|
• at E14.5, mRNA levels of Nkx2-5 (NK2 homeobox 5) and Mef2c (myocyte enhancer factor 2C), two cardiac core transcription factors required for heart formation and development, are significantly decreased in the heart
• at E12.5 and E14.5, cell proliferation is significantly reduced in the myocardium of the LV, RV, and interventricular septum, as determined by the % of BrdU+ cells
• at E14.5, decreased cell proliferation is associated with increased cardiac Cdkn1a (cyclin dependent kinase inhibitor 1A) mRNA and protein levels
• Notch1 signaling is perturbed leading to reduced protein levels of Notch1 intracellular domain (N1ICD) and its downstream targets Hes1 and Hey1, and enhanced full-length (uncleaved) Notch1 protein levels
• no differences in apoptotic cell death are noted in the heart at E12.5 or E14.5
• no change in LC3 II and p62 protein abundance or in ubiquitinated protein levels is noted in the heart at E14.5, indicating normal autophagy
|
• at E14.5, mRNA levels of two cardiomyocyte specific markers, Myh6 (myosin, heavy polypeptide 6, cardiac muscle, alpha) and Myl2 (myosin, light polypeptide 2, regulatory, cardiac, slow; aka MLC2v), are significantly reduced in the heart, suggesting diminished cardiomyocyte differentiation
|
• at E14.5, five of 17 (29.4%) embryos display a VSD combined with DORV
|
• at E14.5, six of 17 embryos (35.3%) display a large VSD combined with an overriding aorta
|
• at E14.5, all (17 o 17) embryos exhibit a membranous ventricular septal defect (VSD)
• among these 17 embryos, six (35.3%) show a VSD without an outflow tract (OFT) defect, another six (35.3%) display a large VSD with an overriding aorta, and five (29.4%) display a VSD with double outlet right ventricle (DORV)
• VSD is also observed at E15.5
|
• at E14.5, all (17 o 17) embryos exhibit a thinned ventricular wall
• thinning of the ventricular wall is also observed at E12.5, E13.5 and E15.5
|
• at E14.5, all (17 o 17) embryos exhibit ventricular dilation
• ventricular dilation is also observed at E12.5, E13.5 and E15.5
|
muscle
• at E14.5, all (17 o 17) embryos exhibit disorganized ventricular trabeculation in both left ventricle (LV) and right ventricle (RV)
• disorganized trabeculation is also observed at E12.5, E13.5 and E15.5
|
cellular
N |
• after vehicle or bafilomycin A1 treatment, primary MEFs isolated from E12.5 embryos show no differences in LC3 II and p62 protein abundance relative to similarly treated wild-type MEFs, indicating a normal autophagic flux
• no change in general autophagy and selective degradation of protein aggregates is noted in the heart at E14.5
|